BR PHARM

횡성태기산산양삼.png

CEO

KIM SEOK SOON

13, Sinpyeong-ro, Jijeong-myeon, Wonju-si, Gangwon-do, Republic of Korea

Company Overview

BR Pharm performs research activities of wide scope of regenerative medicine technologies for the purpose of ensuring comfort and pleasant lives based on core technologies by making use of PDRN.
BR Pharm owns manufacture technology of cell cycling activator of PDRN medicine for producing regenerative medicine, and listed raw material medicine (PDRN) on DMF, and is certified of BGMP (Bulk Good Manufacture Practice) by the Ministry of Food and Drug Safety. Further, BR Pharm cooperates governmental institutes for consumption and supply of safe PDRN raw material medicine.

History

(주)아랜디.png

Outcome

2020.06 Certified of CE – PN Intra articular injection
2020.03 Business compliant with Korea Good Manufacturing Practice (Major category of GMP - Injections)
2019.06 Certified of venture business (R&D business) by Kora SME's and Startups Agency
2019.03 Elected of one of participant companies in Export Voucher Project (Growth)
2019.01 Issued of Certificate of GMP Compliance of a Manufacturer by Seoul Regional Food and Drug Administration
Listed PDRN raw material medicine on DMF (Drug Master File)
2018.12 Won three million Dollar's export award
2018.04 Certified of China FDA (31 items)
2018.03 Elected of IP Star Business
2018.01 Certified of Main-Biz
2017.11 Certified of CE – Cross-linked HA dermal filler
2017.09 Certified of Cosmetic GMP and ISO22716
2016.02 Certified of GMP Compliance of a Manufacturer of medical devices for Factory II (in the general support center of medical devices)
2015.12 Certified of ISO13485 (No. 820083) - Development, Manufacture of Hyaluronic Acid Gel